Curequick Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
CIN U24299HR2022PTC103250 Incorporated 28 April 2022 ROC Delhi HQ Karnal, Haryana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹16.54 Cr
▲ 84% YoY
Net profit · FY 2024
₹8.04 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹30.66 Lakh
EBITDA margin 1.9%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹3 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings

About Curequick Private Limited

Data last updated:

Curequick Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299HR2022PTC103250. Its GSTIN is 06AAKCC2765K1ZD (Haryana).

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Keshav and Rajesh Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 20 Hsiidc Sector – 3 Karnal, Haryana, India – 132001.

As per the financials filed for FY 2024, the company reported a revenue of ₹16.54 Cr, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹8.04 Lakh (net margin 0.5%) and EBITDA of ₹30.66 Lakh (EBITDA margin 1.9%).

As per MCA filings, the company has open charges of ₹3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Curequick Private Limited
CIN U24299HR2022PTC103250
Registration Number 103250
Incorporation Date 28 April 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No 20 Hsiidc Sector – 3 Karnal, Haryana, India – 132001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Curequick Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Curequick Private Limited report

Financials, compliance, directors, charges, ownership and filings for Curequick Private Limited in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Business Activity of Curequick Private Limited

The main business activity of Curequick is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Curequick Private Limited FY 2025 filings available

Curequick Private Limited reported revenue of ₹16.54 Cr (up 84% YoY) for FY 2024.

Revenue · FY 2024
₹16.54 Cr ▲ 84%
Net profit · FY 2024
₹8.04 Lakh margin 0.5%
EBITDA · FY 2024
₹30.66 Lakh margin 1.9%

Compounded Annual Growth Rate (CAGR) of Curequick Private Limited

Revenue CAGR growth
1 year
▲ 84%
EBITDA CAGR growth
1 year
▲ 257%

Revenue rose 84% in the latest year. EBITDA rose 257% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Curequick Private Limited

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations••••••••
Other Income••••••••
Total Revenue••••••••
Cost of Materials Consumed••••••••
Employee Benefit Expense••••••••
Finance Costs••••••••
Depreciation and Amortisation••••••••
Other Expenses••••••••
Total Expenses••••••••
EBITDA₹30.66 Lakh••••
Profit Before Tax••••••••
Tax Expense••••••••
Net Profit (PAT)₹8.04 Lakh••••
Balance Sheet
Share Capital••••••••
Reserves and Surplus••••••••
Net Worth (Total Equity)••••••••
Long-term Borrowings••••••••
Short-term Borrowings••••••••
Trade Payables••••••••
Total Liabilities••••••••
Fixed Assets••••••••
Investments••••••••
Inventories••••••••
Trade Receivables••••••••
Cash and Bank Balance••••••••
Total Assets••••••••

Financial Ratios of Curequick Private Limited

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin1.9%••••
Net Profit Margin0.5%••••
Return on Equity (ROE)••••••••
Return on Capital Employed (ROCE)••••••••
Return on Assets (ROA)••••••••
Liquidity and Debt
Current Ratio••••••••
Quick Ratio••••••••
Debt-to-Equity Ratio••••••••
Interest Coverage Ratio••••••••
Efficiency and Growth
Asset Turnover••••••••
Receivable Days••••••••
Payable Days••••••••
Inventory Days••••••••
Revenue Growth••••••••
Net Profit Growth••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curequick are in the company report.

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Curequick Private Limited

Curequick Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Prohealth Vitamins Private Limited••••••••••••••••-Chandigarh, India
Renocare Pharmaceuticals Private Limited••••••••••••••••136Chennai, Tamil Nadu, India
Kanchanjanga Medipharma Private Limited••••••••••••••••53Siliguri, West Bengal, India
Matias Healthcare Private Limited••••••••••••••••-Indore, Madhya Pradesh, India
Jagrut Pharmaceuticals Private Limited••••••••••••••••-Aurangabad, Maharashtra, India
Curequick Private Limited this company••••••••••••••••-Karnal, Haryana, India
Xena Coronus Health Care Private Limited••••••••••••••••67Indore, Madhya Pradesh, India
Metpharm Biotech Private Limited••••••••••••••••-Navsari, Gujarat, India
Manaar Exports Private Limited••••••••••••••••-Kolhapur, Maharashtra, India
Esvee Pharma Chem Private Limited••••••••••••••••-Pune, Maharashtra, India
BCGS Hospitals Private Limited••••••••••••••••114Bareilly, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Curequick by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Curequick Private Limited

Curequick Private Limited is audited by GROVER DINESH & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
GROVER DINESH & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Curequick Private Limited

Curequick has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
KeshavDirector28 Apr 20224 Years 5 MonthsCurrent
Rajesh KumarDirector28 Apr 20224 Years 5 MonthsCurrent

Ownership and Shareholding of Curequick Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Curequick Private Limited

Open charges
₹3 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹3.00 Cr
Latest charge details
DateLenderAmountStatus
24 Aug 2023State Bank of India₹3 CrOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Curequick Private Limited

Curequick Private Limited has a workforce of 0 employees as of Apr 04, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Curequick Private Limited

Curequick Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Keshav was appointed as Director on 28 Apr 2022.

AGM
Curequick Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Curequick Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with State Bank Of India amounted to Rs. 300.00 Lakh with Charge ID 100811446 was registered on 24 Aug 2023.
Appointed
Keshav was appointed as Director.
Appointed
Rajesh Kumar was appointed as Director.
Incorporation
28 Apr 2022
Curequick Private Limited was registered on 28 Apr 2022 with Roc Delhi & aged 4 years 5 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Curequick Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Curequick Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Curequick Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Curequick Private Limited

Curequick has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAKCC2765K1ZDHaryanaActive04 May 2022
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Curequick Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Curequick Private Limited

Curequick is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 2022 (4+ years old) and is registered under CIN U24299HR2022PTC103250.

Curequick reported revenue of ₹16.54 Cr for FY 2024 (up 84% YoY).

Curequick has 2 current directors:

Curequick reported a net profit of ₹8.04 Lakh (net margin 0.5%) and EBITDA of ₹30.66 Lakh (EBITDA margin 1.9%) for FY 2024, as per its filed financial statements.

The GSTIN of Curequick is 06AAKCC2765K1ZD, registered in Haryana.

The CIN (Corporate Identification Number) of Curequick is U24299HR2022PTC103250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Curequick was incorporated on 28 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Curequick by revenue are Prohealth Vitamins Private Limited, Renocare Pharmaceuticals Private Limited, Kanchanjanga Medipharma Private Limited, Matias Healthcare Private Limited, Jagrut Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Keshav was appointed as Director on 28 Apr 2022. Rajesh Kumar was appointed as Director on 28 Apr 2022.

The registered office of Curequick is at Plot No 20 Hsiidc Sector – 3 Karnal, Haryana, India – 132001.

Curequick has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available